{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 6.57895, "regularMarketPrice": 8.91, "exchange": "NGM", "shortName": "CureVac N.V.", "longName": "CureVac N.V.", "messageBoardId": "finmb_20786046", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "currency": "USD", "marketState": "PRE", "firstTradeDateMilliseconds": 1597411800000, "priceHint": 2, "fiftyTwoWeekLowChange": 3.2799997, "fiftyTwoWeekLowChangePercent": 0.5825932, "fiftyTwoWeekRange": "5.63 - 20.06", "fiftyTwoWeekHighChange": -11.15, "fiftyTwoWeekHighChangePercent": -0.5558325, "fiftyTwoWeekLow": 5.63, "fiftyTwoWeekHigh": 20.06, "earningsTimestamp": 1682427600, "earningsTimestampStart": 1684839540, "earningsTimestampEnd": 1685361600, "trailingAnnualDividendRate": 0.0, "epsTrailingTwelveMonths": -1.4, "epsForward": -0.73, "epsCurrentYear": -1.19, "priceEpsCurrentYear": -7.4873943, "sharesOutstanding": 223842000, "bookValue": 2.735, "fiftyDayAverage": 7.388, "fiftyDayAverageChange": 1.5219998, "fiftyDayAverageChangePercent": 0.20600972, "twoHundredDayAverage": 8.61775, "twoHundredDayAverageChange": 0.29224968, "twoHundredDayAverageChangePercent": 0.033912525, "marketCap": 2073152000, "forwardPE": -12.205479, "priceToBook": 3.2577698, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-08-14", "averageAnalystRating": "2.4 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.5500002, "regularMarketTime": 1684180804, "regularMarketDayHigh": 8.9325, "regularMarketDayRange": "8.36 - 8.9325", "regularMarketDayLow": 8.36, "regularMarketVolume": 832238, "regularMarketPreviousClose": 8.36, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 8, "fullExchangeName": "NasdaqGM", "financialCurrency": "EUR", "regularMarketOpen": 8.39, "averageDailyVolume3Month": 546478, "averageDailyVolume10Day": 632230, "trailingAnnualDividendYield": 0.0, "displayName": "CureVac", "symbol": "CVAC"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Friedrich-Miescher-Strasse 15", "city": "T\u00fcbingen", "zip": "72076", "country": "Germany", "phone": "49 7071 9883 0", "fax": "49 7071 9883 1101", "website": "https://www.curevac.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer therapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. CureVac N.V. was founded in 2000 and is headquartered in T\u00fcbingen, Germany.", "fullTimeEmployees": 904, "companyOfficers": [{"maxAge": 1, "name": "Mr. Pierre  Kemula B.Sc.", "age": 47, "title": "MD, CFO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 600296, "fmt": "600.3k", "longFmt": "600,296"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Igor  Splawski M.Sc., Ph.D.", "age": 53, "title": "Chief Scientific Officer & Member of Management Board", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 528908, "fmt": "528.91k", "longFmt": "528,908"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Antony  Blanc Ph.D.", "age": 52, "title": "MD, Chief Bus. Officer, Chief Commercial Officer & Member of Management Board", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 510944, "fmt": "510.94k", "longFmt": "510,944"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Malte  Greune Ph.D.", "age": 57, "title": "COO, Member of Management Board & MD", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 466857, "fmt": "466.86k", "longFmt": "466,857"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ulrike  Gnad-Vogt M.D., Ph.D.", "age": 49, "title": "Sr. VP & Area Head of Oncology", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 383303, "fmt": "383.3k", "longFmt": "383,303"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Alexander  Zehnder M.B.A., M.D.", "age": 52, "title": "CEO, MD & Member of Management Board", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Myriam  Mendila M.D.", "age": 56, "title": "Chief Devel. Officer, MD & Member of the Management Board", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sarah  Fakih", "title": "VP Corp. Communications & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Marco  Rau L.L.M., Ph.D.", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thorsten  Schuller", "title": "Head of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}